US visitors, please note: This website contains information on the PROGENSA® PCA3 Assay which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or applicable in the USA. View details on US FDA approval for PROGENSA® PCA3 Assay.
There is very limited data on the effect of a urinary tract infection on the performance of the Prostate CAncer gene 3 (PCA3) test. However, there is currently no evidence that the PCA3 test is affected by the presence of a urinary tract infection.